Immutrin

Biotechnology company developing next‑generation antibody therapies

placeCambridge, England, United Kingdom calendar_todayFounded 2019 language immutrin.com

Registered entities

Social engagement

Social engagement: 1.3K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Frazier Life Sciences.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Recent activity

6 May 2026
Leadership hire
Chief Medical Officer
Coming soon